Oakworth Capital, Inc. Eli Lilly & CO Transaction History

Oakworth Capital, Inc.

$1.44 Billion
Q3 2024

A detailed history of Oakworth Capital, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Oakworth Capital, Inc. holds 3,884 shares of LLY stock, worth $3.07 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

3,884

Previous 3,805 2.08%

Holding current value

$3.07 Million

Previous $3.44 Million 0.12%

% of portfolio

0.24%

Previous 0.25%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$772.14 - $960.02 $60,999 - $75,841	79 Added 2.08%	3,884 $3.44 Million
Q2 2024 Jul 19, 2024	BUY	$724.87 - $909.04 $276,175 - $346,344	381 Added 11.13%	3,805 $3.44 Million
Q1 2024 Apr 22, 2024	SELL	$592.2 - $792.28 $123,769 - $165,586	-209 Reduced 5.75%	3,424 $2.66 Million
Q4 2023 Jan 30, 2024	BUY	$525.19 - $619.13 $95,059 - $112,062	181 Added 5.24%	3,633 $2.12 Million
Q3 2023 Oct 31, 2023	BUY	$434.7 - $599.3 $13,041 - $17,979	30 Added 0.88%	3,452 $1.85 Million
Q2 2023 Jul 28, 2023	SELL	$350.74 - $468.98 $192,556 - $257,470	-549 Reduced 13.83%	3,422 $1.6 Million
Q3 2022 Oct 31, 2022	BUY	$296.48 - $337.87 $6,522 - $7,433	22 Added 0.56%	3,971 $1.28 Million
Q1 2022 Apr 11, 2022	SELL	$234.69 - $291.66 $24,642 - $30,624	-105 Reduced 2.59%	3,949 $1.13 Million
Q4 2021 Feb 07, 2022	BUY	$224.85 - $279.04 $46,543 - $57,761	207 Added 5.38%	4,054 $1.12 Million
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $55,400 - $68,177	-250 Reduced 6.1%	3,847 $888,000
Q2 2021 Jul 20, 2021	BUY	$180.55 - $233.54 $45,498 - $58,852	252 Added 6.55%	4,097 $940,000
Q1 2021 Apr 30, 2021	SELL	$164.32 - $212.72 $5,258 - $6,807	-32 Reduced 0.83%	3,845 $718,000
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $2,348 - $3,107	-18 Reduced 0.46%	3,877 $654,000
Q3 2020 Nov 09, 2020	SELL	$146.22 - $169.13 $2,631 - $3,044	-18 Reduced 0.46%	3,895 $577,000
Q2 2020 Aug 11, 2020	BUY	$136.42 - $164.18 $6,820 - $8,209	50 Added 1.29%	3,913 $643,000
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $254,053 - $276,344	-2,379 Reduced 38.11%	3,863 $432,000
Q2 2019 Aug 02, 2019	SELL	$110.79 - $129.32 $10,303 - $12,026	-93 Reduced 1.47%	6,242 $692,000
Q1 2019 May 06, 2019	SELL	$111.31 - $131.02 $8,682 - $10,219	-78 Reduced 1.22%	6,335 $822,000
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $68,940 - $77,234	-651 Reduced 9.22%	6,413 $742,000
Q3 2018 Oct 25, 2018	BUY	$85.86 - $107.31 $944 - $1,180	11 Added 0.16%	7,064 $758,000
Q2 2018 Aug 07, 2018	BUY	$75.7 - $86.88 $53,444 - $61,337	706 Added 11.12%	7,053 $602,000
Q1 2018 May 09, 2018	SELL	$74.21 - $87.6 $67,605 - $79,803	-911 Reduced 12.55%	6,347 $514,000
Q4 2017 Jan 22, 2018	BUY	$81.94 - $87.89 $44,575 - $47,812	544 Added 8.1%	7,258 $614,000
Q3 2017 Nov 08, 2017	BUY	$77.07 - $85.54 $517,447 - $574,315	6,714	6,714 $546,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oakworth Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oakworth Capital, Inc. with notifications on news.

Account

Oakworth Capital, Inc. Eli Lilly & CO Transaction History